Loss of Aryl Hydrocarbon Receptor Promotes Colon Tumorigenesis in Apc Mice

Huajun Han1,2, Laurie A Davidson1,3, Martha Hensel4

  • 1Program in Integrative Nutrition and Complex Diseases, Texas A&M University, College Station, Texas.

Insights

Aryl hydrocarbon receptor (AhR) loss in the gut promotes colon cancer by upregulating Wnt signaling. AhR signaling suppresses Wnt, indicating its potential as a therapeutic target for colon cancer prevention and treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gastroenterology

Background:

  • The genetic drivers of colorectal cancer are known, but how other genes influence them is unclear.
  • The aryl hydrocarbon receptor (AhR) is a transcription factor with an unknown role in colon cancer progression.

Purpose of the Study:

  • To investigate the role of AhR in modulating oncogenic signaling pathways in the colon.
  • To determine if AhR influences colon stem/progenitor cell function and tumorigenesis.

Main Methods:

  • Targeted knockout of AhR in intestinal epithelial cells of mice.
  • Analysis of Wnt signaling pathway activation and colon stem/progenitor cell expansion.
  • Assessment of mouse survival, proliferation, and tumor development in the cecum and colon.

Main Results:

  • AhR knockout in intestinal epithelial cells promoted colonic stem/progenitor cell expansion and Wnt signaling.
  • Loss of AhR increased cell proliferation, reduced survival, and enhanced colon tumorigenesis in mice.
  • Blocking Wnt signaling with Lgr5 partially reversed the pro-tumorigenic effects of AhR loss.

Conclusions:

  • AhR signaling plays a protective role in colon tumorigenesis by suppressing Wnt signaling.
  • Targeting AhR may offer a novel strategy for colon cancer prevention and treatment.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.5K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.7K